The company is free to unblind the data and show that it actually has a benefit. Been over a year since it passed it's primary endpoint. You know, the one generally required for approval.
I can go to Cancer Compass or Inspire GBM forums and cherry pick long term survivors who didn't take DCVax.
Market Data 
Markets 
AI
